Systematic review and meta-analysis of the efficacy and safety of apixaban compared to rivaroxaban in acute VTE in the real world

Both apixaban and rivaroxaban have been approved for use in acute venous thromboembolism (VTE). Although indirect comparison through network meta-analyses of randomized trials have been performed to compare the efficacy and safety of these agents, further comparison between these agents was lacking...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Blood Adv
Päätekijät: Aryal, Madan Raj, Gosain, Rohit, Donato, Anthony, Yu, Han, Katel, Anjan, Bhandari, Yashoda, Dhital, Rashmi, Kouides, Peter A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Hematology 2019
Aiheet:
Systematic Review
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6693001/
https://ncbi.nlm.nih.gov/pubmed/31405948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000572
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia